Aethlon Medical (AEMD) executive compensation, 2026 proxy

James B. Frakes, Chief Executive Officer and Chief Financial Officer, was paid $826,922 in 2026, up 65% from $500,000 the year before.

Filed
September 1, 2026
Annual meeting
October 1, 2026
Pay year
2026
Named executives
3
CEO total pay
$826,922+65% vs prior year
CEO discretionary bonus
$250,000
LaRosa salary
$473,000Increased effective April 1, 2025
LaRosa target bonus
40%Target of base salary
Cipriani severance
$211,250Fiscal 2026 payment
NEO equity awards
NoneNo awards approved

How Frakes was paid

$826,922 in total for 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary60%All other compensation40%

Named executive officers

ExecutiveTotal
James B. FrakesChief Executive Officer and Chief Financial Officer$826,922
Steven P. LaRosa, M.D.Chief Medical Officer$593,480
Guy F. CiprianiFormer Senior Vice President, Chief Operating Officer$211,250

What changed and why

  • $827K2026 CEO total compensation was $826,922, up from $500,000 in 2025 due to bonus and vacation payout.
  • $250K$250,000 discretionary cash bonus and $76,922 vacation payout comprised the CEO’s $326,922 all-other compensation.
  • $75,000$75,000 discretionary cash bonus and $45,480 vacation payout comprised Dr. LaRosa’s $120,480 all-other compensation.
  • No named executive officers received equity-based incentive awards in fiscal 2026.
  • $211K$211,250 severance payment comprised Mr. Cipriani’s fiscal 2026 compensation.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.